Related Experiment Video
Updated: Feb 4, 2026
08:21
Author Spotlight: A Pharmacodissection Approach to Uncover Mechanisms in Cardiovascular Disease Risk Populations
Published on: July 21, 2023
2.1K
Evaluation and management of defecatory dysfunction in women
1Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Kaiser Permanente East Bay-University of California, San Francisco.
Current Opinion in Obstetrics & Gynecology
|September 25, 2018
Summary
Defecatory dysfunction in women is common and complex, often linked to other pelvic floor disorders. Conservative treatments are primary, with surgery reserved for specific cases, and multidisciplinary care is recommended.
Area of Science:
- Urogynecology
- Pelvic Floor Disorders
- Women's Health
Background:
- Pelvic floor disorders, including defecatory dysfunction, significantly impact women's health.
- These conditions are highly prevalent and can be complex to manage.
Purpose of the Study:
- To review current recommendations for evaluating and managing defecatory dysfunction in women.
- To highlight the connections between defecatory dysfunction and other pelvic floor disorders like pelvic organ prolapse, fecal incontinence, and voiding dysfunction.
Main Methods:
- Review of current clinical recommendations and literature.
- Analysis of the interrelationships between various pelvic floor disorders.
Main Results:
- Conservative management (lifestyle, pharmacotherapy, biofeedback) remains the primary treatment approach.
- Physiologic testing or imaging is indicated for complex or treatment-resistant cases.
- Surgical intervention is reserved for select patients with anatomical causes.
Conclusions:
- Effective management of defecatory dysfunction often requires a multidisciplinary approach.
- Further research is needed on surgical outcomes and patient expectations.
More Related Videos
Related Concept Videos
01:26Tonsillitis II: Management
430
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
430
01:29Impression Management Techniques I: Managing Appearances
218
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
218
01:19Managing Impressions
173
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
173
01:19Management of Insomnia
647
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
647
01:24Cystic Fibrosis: Management
543
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
543
01:26Angina IV: Management
291
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
291